Company*
(Country;
Symbol)

Company*
(Country;
Symbol)

Product

Terms/Details (Date)


Asuragen Inc.*

Digene Corp.
(DIGE)

Worldwide deal for the marketing and distribution of Asuragen's cystic fibrosis screening products

Digene gets exclusive rights to market the products, as well as follow-on products; Asuragen gets an up-front payment and potential milestone payments (4/19)#

CombiMatrix
Group
(CBMX)

Prisma Biotech Corp.* (Taiwan)

Prisma will promote and sell CombiMatrix products in Taiwan, China and certain other countries

Prisma also can synthesize content onto CombiMatrix CustomArrays and sell those arrays to end customers; terms were not disclosed (4/28)

Nabi Bio-
pharmaceuticals
(NABI)

Inhibitex Inc.
(INHX)

Inhibitex terminated deal covering the manufacture of its Veronate product

The move follows a failed Phase III trial of Veronate for preventing hospital-associated infections in premature, very low-birth infants (4/28)


Notes:

* Private companies are indicated with an asterisk.

# Item occurred before the time frame of this chart but was not included in the previous chart.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

No Comments